Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
TerSera Therapeutics LLC Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of TerSera Therapeutics LLC, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Reborna Biosciences, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Reborna Biosciences, Inc., covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
SCAI Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of SCAI Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Orikine Bio SL Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Orikine Bio SL, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
OnCusp Therapeutics Inc Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of OnCusp Therapeutics Inc, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
ATB Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of ATB Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Onchilles Pharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Onchilles Pharma, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Aliad Biopharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Aliad Biopharma, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Ansun Biopharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Ansun Biopharma, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Merz Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Merz Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Mirador Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Mirador Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Algok Bio Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
14 August 2026
A 2026 BD opportunity scan of Algok Bio Inc., covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.